BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10810746)

  • 1. Disintegration propensity of tablets evaluated by means of disintegrating force kinetics.
    Massimo G; Catellani PL; Santi P; Bettini R; Vaona G; Bonfanti A; Maggi L; Colombo P
    Pharm Dev Technol; 2000; 5(2):163-9. PubMed ID: 10810746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of a novel automatic disintegration apparatus for the development and evaluation of a direct compression rapidly disintegrating tablet.
    Jung HA; Augsburger LL
    Drug Dev Ind Pharm; 2012 Jul; 38(7):825-36. PubMed ID: 22091970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of different fast melting disintegrants by means of a central composite design.
    Di Martino P; Martelli S; Wehrlé P
    Drug Dev Ind Pharm; 2005 Jan; 31(1):109-21. PubMed ID: 15704862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of tablet disintegrants: impact of storage conditions and relative tablet density.
    Quodbach J; Kleinebudde P
    Pharm Dev Technol; 2015; 20(6):762-8. PubMed ID: 24848093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
    Mehta S; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera.
    Morita Y; Tsushima Y; Yasui M; Termoz R; Ajioka J; Takayama K
    Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1181-6. PubMed ID: 12237533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
    Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
    Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing robust immediate release tablet formulations avoiding food effects for BCS class 3 drugs.
    Zaheer K; Langguth P
    Eur J Pharm Biopharm; 2019 Jun; 139():177-185. PubMed ID: 30902732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational estimation of the optimum amount of non-fibrous disintegrant applying percolation theory for binary fast disintegrating formulation.
    Krausbauer E; Puchkov M; Betz G; Leuenberger H
    J Pharm Sci; 2008 Jan; 97(1):529-41. PubMed ID: 17879295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity.
    Bi Y; Sunada H; Yonezawa Y; Danjo K; Otsuka A; Iida K
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2121-7. PubMed ID: 8945778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The suitability of disintegrating force kinetics for studying the effect of manufacturing parameters on spironolactone tablet properties.
    Massimo G; Santi P; Colombo G; Nicoli S; Zani F; Colombo P; Bettini R
    AAPS PharmSciTech; 2003; 4(2):E17. PubMed ID: 12916899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of coprocessed disintegrants produced from tapioca starch and mannitol in orally disintegrating paracetamol tablet.
    Adeoye O; Alebiowu G
    Acta Pol Pharm; 2014; 71(5):803-11. PubMed ID: 25362809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the disintegration properties of microcrystalline cellulose II and commercial disintegrants.
    Rojas J; Kumar V
    Pharmazie; 2012 Jun; 67(6):500-6. PubMed ID: 22822537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of Disintegrants and the Disintegration Phenomena.
    Desai PM; Liew CV; Heng PWS
    J Pharm Sci; 2016 Sep; 105(9):2545-2555. PubMed ID: 27506604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose.
    Fukami J; Yonemochi E; Yoshihashi Y; Terada K
    Int J Pharm; 2006 Mar; 310(1-2):101-9. PubMed ID: 16434157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclodextrin polymer, a new tablet disintegrating agent.
    Fenyvest E; Antal B; Zsadon B; Szejtli J
    Pharmazie; 1984 Jul; 39(7):473-5. PubMed ID: 6494226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of tablet disintegrants and magnesium stearate during mixing I: Effect on tablet disintegration.
    Bolhuis GK; Smallenbroek AJ; Lerk CF
    J Pharm Sci; 1981 Dec; 70(12):1328-30. PubMed ID: 7320846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic classification of tablet disintegrants by water uptake and force development kinetics.
    Quodbach J; Kleinebudde P
    J Pharm Pharmacol; 2014 Oct; 66(10):1429-38. PubMed ID: 24943882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disintegrating force as a new formulation parameter.
    Colombo P; Conte U; Caramella C; Geddo M; La Manna A
    J Pharm Sci; 1984 May; 73(5):701-5. PubMed ID: 6737250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of swelling capacity of superdisintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressed tablets.
    Zhao N; Augsburger LL
    AAPS PharmSciTech; 2005 Sep; 6(1):E120-6. PubMed ID: 16353956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.